
The State of Play in Biotech and the Decisions Shaping the Industry
Aug 12, 2026 - 60:58
Radio and PodcastLive Radio & Podcasts
On this episode of Strategic Intent, In Vivo’s David Wild sits down with Doug Love, President and CEO of Annexon Inc., to discuss how the company is transitioning from a platform-centric biotech into a commercial organiz...
Strategic Intent: First-in-class, two markets: Annexon’s GBS and GA Strategies is an episode from Pharma Intelligence Podcasts. On this episode of Strategic Intent, In Vivo’s David Wild sits down with Doug Love, President and CEO of Annexon...
This episode belongs to Pharma Intelligence Podcasts.
Use the player on this page to stream the episode online.
Published Aug 11, 2026, 33:35 long, audio available.